-+ 0.00%
-+ 0.00%
-+ 0.00%

MAPLIGHT - GAINS EXCLUSIVE RIGHTS FOR CLINICAL DEVELOPMENT, COMMERCIALIZATION OF COLLABORATION COMPOUNDS

Reuters·12/16/2025 12:00:01

Please log in to view news